Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tailor-made medicine for diabetes].

Mitsuhiko Noda1

  • 1Institute for Diabetes Care and Research, Asahi Life Foundation.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 26, 2002
PubMed
Summary

Identifying specific diabetes susceptibility genes, like PPAR gamma, offers a path to personalized medicine. This genetic insight aids in tailoring diabetes prevention and treatment strategies for individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting future kidney function in type 2 diabetes mellitus using machine learning and baseline health information.

Scientific reports·2026
Same author

Baseline characteristics of patients with type 1 and type 2 diabetes in the Asahi Diabetes Complications Study (Asahi Study): a clinic-based prospective observational study.

Diabetology international·2026
Same author

Safety of anagliptin/metformin combination tablets evaluated by non-inferiority between pre- and post-serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY).

Journal of diabetes investigation·2026
Same author

Regional Differences and Similarities in Diabetes Care in Japan: Insights from the J-DOME Registry.

JMA journal·2025
Same author

Antidiabetic agents and dementia risk in type 2 diabetes: A systematic review and network meta-analysis.

Diabetes, obesity & metabolism·2025
Same author

Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial.

JAMA ophthalmology·2025

Area of Science:

  • Genetics
  • Metabolic Diseases
  • Pharmacogenomics

Context:

  • Diabetes mellitus, particularly type 2, is a complex metabolic disease influenced by multiple genetic factors.
  • Gene polymorphisms in peroxisome proliferator-activated receptor-gamma (PPAR gamma), adiponectin, and beta 3-adrenergic receptor are associated with diabetes risk.
  • Understanding these genetic underpinnings is crucial for advancing diabetes care.

Purpose:

  • To explore the role of specific gene polymorphisms in the susceptibility to diabetes.
  • To highlight the potential of genetic analysis in developing personalized diabetes treatment and prevention strategies.

Summary:

  • Several genes, including peroxisome proliferator-activated receptor-gamma (PPAR gamma), adiponectin, and beta 3-adrenergic receptor, are linked to diabetes development.
  • Polymorphisms in these genes significantly influence an individual's risk and response to diabetes treatments.
  • Genetic profiling can guide the selection of optimal therapeutic interventions and drug development for diabetes.

Impact:

  • Facilitates the development of tailor-made medicine for diabetes, improving treatment efficacy.
  • Enables personalized prevention strategies for type 2 diabetes based on individual genetic profiles.
  • Advances the field of precision medicine for lifestyle diseases through genetic discovery.

Related Experiment Videos